Showing results (71-80 of 518) with videos related to
Sort By:
Pageof 52
The International Journal of Biological Markers|July 1, 1993
The role of cytokines in the modulation of cell surface antigens of human melanomaA Anichini, R Mortarini, G ParmianiInternational Journal of Cancer|June 15, 1987
Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigensG Fossati, A Anichini, G ParmianiCancer Immunology, Immunotherapy : CII|January 1, 1987
Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcomaL Grazioli, M Sensi, G ParmianiInternational Journal of Cancer|February 20, 1991
Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteinsR Mortarini, A Anichini, G ParmianiHuman Gene Therapy|July 13, 2000
Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisalG Parmiani, M Rodolfo, C MelaniExperimental and Clinical Immunogenetics|January 1, 1991
Recombinant interferon-gamma differently affects DQA and DRA gene expression in two human melanoma clones: transcriptional and posttranscriptional regulationC Castelli, M Sensi, G ParmianiImmunology Today|October 8, 2014
Allostimulation-induced tumor cytotoxic cells: from mouse to manG Parmiani, M Sensi, G FossatiMelanoma Research|August 1, 1997
New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responsesG Parmiani, A Anichini, C CastelliInternational Journal of Cancer|October 15, 1980
Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcomaG Parmiani, M Colombo, D BallinariCancer Immunology, Immunotherapy : CII|January 1, 1986
Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cellsM Sensi, L Grazioli, G ParmianiPageof 52